eFFECTOR Therapeutics Inc

NASDAQ:EFTR 4:00:00 PM EDT

1.81

-0.04 (-2.16%)

7:57:32 PM EDT: $1.86 +0.05 (+2.76%)

eFFECTOR Therapeutics Inc Stock, NASDAQ:EFTR

142 North Cedros Avenue, Suite B, Solana Beach, California 92075

United States of America

Phone: +1.858.925.8215

Number of Employees: 14

http://www.effector.com

Description

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in Solana Beach, CA.